PDS Biotechnology (PDSB) Files $200M Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Tweet
Share
E-mailGet Alerts PDSB Hot Sheet
Join SI Premium – FREE
PDS Biotechnology (NASDAQ: PDSB) has filed $200,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Rights to Purchase Common Stock, Preferred Stock,
Debt Securities or Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. to announce certification of Boeing 737 Max 10 on Tuesday - Reuters
- Medtronic names Michael Marinaro as president with expanded role
- Marriott Vacations Worldwide names new chief revenue officer
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
